These transgenic mice express a tamoxifen-inducible Cre recombinase under the control of the mouse I12b enhancer element of Dlx1/2, and may be useful for generating temporal conditional mutations for studying gain or loss of function and/or fate mapping in Dlx1/2-expressing forebrain tissues, including interneurons of the olfactory bulb and neocortex.
Gord Fishell, Harvard Medical School
Genetic Background | Generation |
---|---|
|
Allele Type |
---|
Transgenic (Recombinase-expressing, Inducible) |
These transgenic mice have a tamoxifen inducible Cre-mediated recombination system driven by the mouse Dlx1/2, distal-less homeobox 1, distal-less homeobox 2, forebrain enhancer/ promoter (I12b). The transgene insert contains a fusion product involving Cre recombinase and a mutant form of the mouse estrogen receptor ligand binding domain, and the human placental alkaline phosphatase (ALPP or PLAP). The mutant mouse estrogen receptor does not bind natural ligand at physiological concentrations but will bind the synthetic ligand, 4-hydroxytamoxifen. Restricted to the cytoplasm, the Cre/ESR1 protein can only gain access to the nuclear compartment after exposure to tamoxifen. When crossed with a strain containing loxP site flanked sequences, the flanked sequences will be deleted in the cre-expressing tissues in the offspring upon administration of tamoxifen. Tamoxifen administration induces Cre recombination in the ventral telencephalon and diencephalon as early as embryonic day 10.5 and in the olfactory bulb interneurons as early as embryonic day 15.5. Inducible recombinase activity occurs in olfactory bulb interneuron precursors throughout adulthood. The expression pattern of the transgene is similar to the endogenous forebrain expression pattern of Dlx1/2 as detected by alkaline phosphatase, placental (PLAP) histochemical analysis. Hemizygous mutant mice are viable, fertile, normal in size and do not display any gross physical or behavioral abnormalities. The Donating Investigator has not attempted to make the strain homozygous.
A targeting construct containing sequence encoding cre/ESR1 (CreERT2) under the control of the mouse Dlx1/2, distal-less homeobox 1, distal-less homeobox 2, forebrain enhancer/ promoter (I12b), an internal ribosomal entry sequence (IRES), the human ALPP, alkaline phosphatase, placental, (PLAP) gene, and SV40 polyadenylation site sequence, was microinjected into FVB/N donor eggs. Founder line 37 was subsequently established. The transgenic mice were then crossed to outbred Swiss Webster mice.
Upon arrival at The Jackson Laboratory, the mice were crossed to FVB/NJ (Stock No. 001800) at least once to establish the colony.
Expressed Gene | ESR1, estrogen receptor 1, human |
---|---|
Expressed Gene | ALPP, alkaline phosphatase, placental, human |
Expressed Gene | cre, cre recombinase, bacteriophage P1 |
Site of Expression | Tamoxifen administration induces Cre recombination in the ventral telencephalon and diencephalon as early as embryonic day 10.5 and in the olfactory bulb interneurons as early as embryonic day 15.5. |
Allele Name | transgene insertion 37, Gordon Fishell |
---|---|
Allele Type | Transgenic (Recombinase-expressing, Inducible) |
Allele Synonym(s) | Tg(Dlx1/2-cre/ERT2,-ALPP)37Fsh |
Gene Symbol and Name | Tg(I12b-cre/ERT2,-ALPP)37Fsh, transgene insertion 37, Gordon Fishell |
Gene Synonym(s) | |
Promoter | Dlx1, distal-less homeobox 1, mouse, laboratory |
Expressed Gene | ESR1, estrogen receptor 1, human |
Expressed Gene | ALPP, alkaline phosphatase, placental, human |
Expressed Gene | cre, cre recombinase, bacteriophage P1 |
Site of Expression | Tamoxifen administration induces Cre recombination in the ventral telencephalon and diencephalon as early as embryonic day 10.5 and in the olfactory bulb interneurons as early as embryonic day 15.5. |
Strain of Origin | FVB/N |
Chromosome | UN |
Molecular Note | A targeting construct containing sequence encoding xre/ERT2 under the control of the mouse Dlx1/2, distal-less homeobox 1, distal-less homeobox 2, forebrain enhancer/ promoter, I12b, with an internal ribosomal entry sequence (IRES), followed by the human placental alkaline phosphatase gene (ALPP), and SV40 polyadenylation site sequence, was microinjected into FVB/N donor eggs. Founder line 37 was subsequently established. |
Mutations Made By | Rob Machold, The Skirball Institute, NYU Sch. of Med. |
When maintaining a live colony, these mice can be bred as hemizygotes.
When using the STOCK Tg(I12b-cre/ERT2,-ALPP)37Fsh/J mouse strain in a publication, please cite the originating article(s) and include JAX stock #014600 in your Materials and Methods section.
Facility Barrier Level Descriptions
Service/Product | Description | Price |
---|---|---|
Hemizygous or Non carrier for Tg(I12b-cre/ERT2,-ALPP)37Fsh |
Frozen Mouse Embryo | STOCK Tg(I12b-cre/ERT2-ALPP)37Fsh/J | $2595.00 |
Frozen Mouse Embryo | STOCK Tg(I12b-cre/ERT2-ALPP)37Fsh/J | $2595.00 |
Frozen Mouse Embryo | STOCK Tg(I12b-cre/ERT2-ALPP)37Fsh/J | $3373.50 |
Frozen Mouse Embryo | STOCK Tg(I12b-cre/ERT2-ALPP)37Fsh/J | $3373.50 |
Terms are granted by individual review and stated on the customer invoice(s) and account statement. These transactions are payable in U.S. currency within the granted terms. Payment for services, products, shipping containers, and shipping costs that are rendered are expected within the payment terms indicated on the invoice or stated by contract. Invoices and account balances in arrears of stated terms may result in The Jackson Laboratory pursuing collection activities including but not limited to outside agencies and court filings.
The Jackson Laboratory has rigorous genetic quality control and mutant gene genotyping programs to ensure the genetic background of JAX® Mice strains as well as the genotypes of strains with identified molecular mutations. JAX® Mice strains are only made available to researchers after meeting our standards. However, the phenotype of each strain may not be fully characterized and/or captured in the strain data sheets. Therefore, we cannot guarantee a strain's phenotype will meet all expectations. To ensure that JAX® Mice will meet the needs of individual research projects or when requesting a strain that is new to your research, we suggest ordering and performing tests on a small number of mice to determine suitability for your particular project. We do not guarantee breeding performance and therefore suggest that investigators order more than one breeding pair to avoid delays in their research.
What information were you hoping to find through your search?
How easy was it to find what you were looking for?
We may wish to follow up with you. Enter your email if you are happy for us to connect and reachout to you with more questions.
Please Enter a Valid Email Address
Thank you for sharing your feedback! We are working on improving the JAX Mice search. Come back soon for exciting changes.